Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: a safe combination.

R. Hoekstra; FYFL de Vos; F.A. Eskens; E.G.E. de Vries; D.R.A. Uges; R.T. Knight; R.A. Carr; R.A. Humerickhouse; J Verweij; J.A. Gietema

Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: a safe combination.

R. Hoekstra
, FYFL de Vos
, F.A. Eskens
, E.G.E. de Vries
, D.R.A. Uges
, R.T. Knight
, R.A. Carr
, R.A. Humerickhouse
, J Verweij
, J.A. Gietema

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	467-472
Journal	European Journal of Cancer
Publication status	Published - Mar 2006

Cite this

@article{34c00dd465094d4ea61e85283d04d24f,

title = "Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: a safe combination.",

author = "R. Hoekstra and \{de Vos\}, FYFL and F.A. Eskens and \{de Vries\}, E.G.E. and D.R.A. Uges and R.T. Knight and R.A. Carr and R.A. Humerickhouse and J Verweij and J.A. Gietema",

year = "2006",

month = mar,

language = "English",

pages = "467--472",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: a safe combination.

AU - Hoekstra, R.

AU - de Vos, FYFL

AU - Eskens, F.A.

AU - de Vries, E.G.E.

AU - Uges, D.R.A.

AU - Knight, R.T.

AU - Carr, R.A.

AU - Humerickhouse, R.A.

AU - Verweij, J

AU - Gietema, J.A.

PY - 2006/3

Y1 - 2006/3

M3 - Article

SN - 0959-8049

SP - 467

EP - 472

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -